BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26887622)

  • 1. [Prognostic analysis of benign, borderline and malignant phyllodes tumors of the breast].
    Wang H; Wang X; Wang C
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):923-7. PubMed ID: 26887622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
    Wang H; Wang X; Wang CF
    Asian Pac J Cancer Prev; 2014; 15(24):10791-5. PubMed ID: 25605178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
    Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
    Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence.
    Li Y; Song Y; Lang R; Shi L; Gao S; Liu H; Wang P
    Breast; 2021 Jun; 57():62-70. PubMed ID: 33774460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
    Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
    Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign Phyllodes Tumor of the Breast Diagnosed After Ultrasound-Guided Vacuum-Assisted Biopsy: Surgical Excision or Wait-and-Watch?
    Ouyang Q; Li S; Tan C; Zeng Y; Zhu L; Song E; Chen K; Su F
    Ann Surg Oncol; 2016 Apr; 23(4):1129-34. PubMed ID: 26577125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.
    Wang F; Jia Y; Tong Z
    Jpn J Clin Oncol; 2015 Feb; 45(2):146-52. PubMed ID: 25387733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast.
    Koh VCY; Thike AA; Nasir NDM; Yip GWC; Bay BH; Tan PH
    Virchows Arch; 2018 Apr; 472(4):615-621. PubMed ID: 29127495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis analysis of local recurrence after excision of breast phyllodes tumors].
    Peng Y; Zhang YY; Wang SC; Wu JB; Tong FZ; Liu P; Cao YM; Zhou B; Cheng L; Liu M; Liu HJ; Guo JJ; Xie F; Yang HP; Wang SY; Wang CB; Wang S
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):116-120. PubMed ID: 33378803
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
    Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
    Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllodes tumors of the breast: Analysis of 35 cases from a single institution.
    Demian GA; Fayaz S; El-Sayed Eissa H; Nazmy N; Samir S; George T; El-Sherify M; Abuzalouf S
    J Egypt Natl Canc Inst; 2016 Dec; 28(4):243-248. PubMed ID: 27406381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
    Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
    Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.
    Feakins RM; Mulcahy HE; Nickols CD; Wells CA
    Histopathology; 1999 Aug; 35(2):162-9. PubMed ID: 10460662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan.
    Lin CC; Chang HW; Lin CY; Chiu CF; Yeh SP
    Int J Clin Oncol; 2013 Aug; 18(4):614-20. PubMed ID: 22773245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast.
    Abdalla HM; Sakr MA
    J Egypt Natl Canc Inst; 2006 Jun; 18(2):125-33. PubMed ID: 17496937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective review of phyllodes tumours of the breast: A single institution experience.
    Ganesh V; Drost L; Lee J; Wan BA; Zhang L; Rakovitch E; Vesprini D; Slodkowska E; Zeng KL; Sousa P; Yee C; Lam H; Chow E
    Breast; 2018 Apr; 38():52-57. PubMed ID: 29232600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric fibroepithelial lesions revisited: pathological insights.
    Tay TK; Chang KT; Thike AA; Tan PH
    J Clin Pathol; 2015 Aug; 68(8):633-41. PubMed ID: 25998513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast.
    Feng X; Zhao L; Shen H; Liu X; Yang Y; Lv S; Niu Y
    Oncotarget; 2017 May; 8(20):33365-33374. PubMed ID: 28380418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast.
    Jang JH; Choi MY; Lee SK; Kim S; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Cho EY; Lee JE; Nam SJ; Yang JH
    Ann Surg Oncol; 2012 Aug; 19(8):2612-7. PubMed ID: 22476816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.